derinet® Switzerland

Tracker Certificate Open End in CHF on the Vontobel Gene Therapy Performance-Index

  • Valor 41884597
  • ISIN CH0418845977
  • Symbol ZGENCV
Bid (indicative)
Ask (indicative)
Price on
Vontobel Gene Therapy Performance IndexUSD 
Please note that this is an indication.


Gene Therapy

Gene Therapy

28 June 2019

2017 has been seen as a breakthrough year for gene therapy, which could soon be used to cure aggressive forms of cancer, AIDS and even hereditary diseases. Gene therapy is a key technology in the healthcare sector that is regarded as having great potential. Could it be a megatrend that investors will profit from in the near future? Provided the market players involved achieve commercial success, including it in a portfolio at an early stage could add an innovative touch. Besides attractive return prospects, gene therapy offers diversification benefits for a classic investment portfolio that consists mainly of core investments or only contains “conventional” pharmaceuticals.


26/06/2022 09:43:56